Ceri Bygrave
13PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Apr 14, 2026
Benefit of selinexor dose reduction on outcomes with selinexor, bortezomib and dexamethasone in patients with lenalidomide-refractory multiple myeloma: Subgroup analysis of the BOSTON trial.Sosana Delimpasi, Ivan Špička, Jason P Butler
|Oct 17, 2024
Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case series.Nini Aung, Margaret Bowers, Gillian Brearton
|Sep 09, 2024
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper.Martin Kaiser, Vicky Goh, Simon Stern
|Jul 02, 2024
Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper.Martin Kaiser, Guy Pratt, Ceri Bygrave
|Apr 18, 2024
Challenges in designing and running smouldering myeloma interventional clinical trials.Catherine Lecat, Eileen M Boyle, Daniel Hughes
|Jan 03, 2024
Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.Jahanzaib Khwaja, Joshua Bomsztyk, Maria Atta
Pageof 3
Frequent Collaborators
4 joint publications
Guy Pratt
4 joint publications
Martin Kaiser
4 joint publications
Kwee Yong
3 joint publications
Rakesh Popat
2 joint publications
Simon Stern
2 joint publications
Gordon Cook
2 joint publications
Oonagh Sheehy
2 joint publications
Marquita Camilleri
2 joint publications
Firas Al-Kaisi
1 joint publications
Caroline L Alvares
